Skip to content
Home/Companies/Healthcare/Pharmaspectra

Pharmaspectra

Healthcare·UK·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns Pharmaspectra?

Pharmaspectra was owned by Inflexion through Inflexion Enterprise Fund V (2019 vintage) from 2019 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-14

Inflexion
Investor
Inflexion
Inflexion Enterprise Fund V · 2019 · Growth

Key facts

HQUK
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Inflexion Enterprise Fund V

Other portfolio companies in the same fund.

Celnor
Celnor
Active
Business ServicesUK· 2023
TC Group
TC Group
Active
Business ServicesUK· 2023
DR&P
Exited 2024
FinancialsUK· 2021
to
The Goat Agency
The Goat Agency
Exited 2023
AdTechUK· 2021
to
Automotive Transformation Group
Exited 2024
TMTUK· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Pharmaspectra

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Pharmaspectra?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Pharmaspectra.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue